Benjamin J Renquist, PhD

Clinical and Translational Oncology Program

Biography

Renquist Lab Research aims to address the causes and consequent diseases of obesity. Although as scientists we are trained to limit the expectations of our findings, we unabashedly maintain that our research goal is to eliminate obesity or the pathophysiologies of obesity. This goal maintains our research focus on addressing a societal issue that affects nearly two-thirds of Americans. To this end we have research focused on 1) type 2 diabetes and obesity associated hypertension, 2) development of effective chemotherapeutics for cancer, and 3) central nervous system control of visceral blood flow and food intake.

Cancer Focus

Renquist lab research is aimed at obesity associated cancers. We specifically aim to 1) develop effective ligand targeted chemotherapeutics and 2) identify variables that encourage progression of cancer in obesity.